LBA27 First-in-human Results of STX-478, a Mutant-Selective PI3Ka Inhibitor, in Advanced Solid Tumor Patients
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined